Effects of Non-surgical Periodontal Therapy on Cardiovascular Risk
1 other identifier
interventional
376
1 country
2
Brief Summary
This study is to evaluate whether non-surgical periodontal therapy can help to control the cardiovascular risk among patients with moderate/severe periodontitis and at risk of cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cardiovascular-diseases
Started Aug 2022
Longer than P75 for not_applicable cardiovascular-diseases
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2022
CompletedFirst Posted
Study publicly available on registry
July 15, 2022
CompletedStudy Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJuly 15, 2022
May 1, 2022
3.1 years
July 5, 2022
July 12, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Cardiovascular risk (Framingham risk score (FRS)) at 1 year.
Cardiovascular risk is assessed by "Framingham risk score (FRS)". (Circulation, 2008,117(6): 743-753.) Generally, the "Framingham risk score (FRS)" ranges from -4 to 33 for men and -5 to 33 for women. A higher "Framingham risk score (FRS)" means a higher risk of developing cardiovascular disease.
Baseline; 1 year
Secondary Outcomes (16)
Change from baseline systolic blood pressure at 1 year after enrollment.
Baseline; 1 year
Change from baseline diastolic blood pressure at 1 year after enrollment.
Baseline; 1 year
Change from baseline fasting blood glucose at 1 year after enrollment.
Baseline; 1 year
Change from baseline glycosylated hemoglobin at 1 year after enrollment.
Baseline; 1 year
Change from baseline total cholesterol at 1 year after enrollment.
Baseline; 1 year
- +11 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTAL1. Basic oral hygiene instructions. 2. Full-mouth subgingival scaling and root planing under local anesthesia. 3. Additional full-mouth subgingival scaling and root planing under local anesthesia every 3 months during the follow-up period if necessary.
Control arm
PLACEBO COMPARATOR1. Basic oral hygiene instructions. 2. Full-mouth supragingival ultrasonic scaling.
Interventions
Non-surgical periodontal therapy includes basic oral hygiene instructions and full-mouth subgingival scaling and root planing under local anesthesia.
Control periodontal treatment includes basic oral hygiene instructions and full-mouth supragingival ultrasonic scaling.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years;
- At risk of cardiovascular disease (defined as "Framingham Score" predicted 10-year risk of cardiovascular disease ≥ 20%);
- Moderate//severe periodontitis;
You may not qualify if:
- Cardiovascular diseases at baseline (coronary heart disease, stroke and peripheral artery disease);
- Received periodontal treatment within the past 6 months;
- Pregnant or lactating females;
- Non residents of Guangzhou and its surrounding cities or expected to leave Guangzhou or its surrounding cities within 1 year;
- Malignant tumors or other end-stage diseases with life expectancy less than 1 year;
- End-stage renal disease;
- Patients with high bleeding risk, high blood pressures or other situations that make them unable to receive interventions;
- Refuse to provide informed consent;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Stomatological Hospital, Southern Medical University
Guangzhou, Guangdong, 510280, China
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, 510515, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiancheng Xiu, MD
Nanfang Hospital, Southern Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Due to the characteristics of the intervention in this trial, it would be impossible to blind the enrolled participants. However, the investigators and outcomes assessors will be blinded. Allocation to arms will be concealed in an envelope and revealed to the stomatologist and patient before delivering the first treatment. Other investigators like outcomes assessors and staff involved in the data collection and analyses will be masked.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2022
First Posted
July 15, 2022
Study Start
August 1, 2022
Primary Completion
August 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
July 15, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share